Skip to content

Drug interactions

Lemborexant + Lomustine

Severity: Minor

Lemborexant and Lomustine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lemborexant is a CYP3A4 substrate whose exposure rises with CYP3A4 inhibitors, increasing somnolence and next-day impairment. Lomustine is not an established CYP3A4 inhibitor, so any effect is theoretical.

What this interaction means in plain words

Lemborexant and Lomustine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lemborexant belongs to Central Nervous System; Lomustine belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by lomustine, which is not well established.

What to do

No routine dose change; monitor for excessive sedation and next-day drowsiness, and reduce the lemborexant dose if these occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lemborexant and Lomustine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lemborexant with Lomustine?

MediHelp rates the interaction as minor. Lemborexant and Lomustine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lemborexant is a CYP3A4 substrate whose exposure rises with CYP3A4 inhibitors, increasing somnolence and next-day impairment. Lomustine is not an established CYP3A4 inhibitor, so any effect is theoretical.

How serious is the interaction between Lemborexant and Lomustine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change; monitor for excessive sedation and next-day drowsiness, and reduce the lemborexant dose if these occur.

What other medicines interact with Lomustine?

MediHelp also lists interactions of Lomustine with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Lomustine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in